|1.||Omboni, Stefano: 15 articles (05/2015 - 06/2010)|
|2.||Benedetto, Chiara: 14 articles (05/2015 - 05/2008)|
|3.||Allais, Gianni: 14 articles (05/2015 - 05/2008)|
|4.||Bussone, Gennaro: 11 articles (05/2015 - 05/2008)|
|5.||Zava, Dario: 11 articles (05/2014 - 06/2010)|
|6.||Tullo, Vincenzo: 10 articles (05/2015 - 06/2010)|
|7.||Savi, Lidia: 7 articles (01/2015 - 04/2011)|
|8.||Ferrari, Michel D: 7 articles (07/2012 - 06/2010)|
|9.||Keywood, Charlotte: 7 articles (05/2009 - 04/2002)|
|10.||Lisotto, Carlo: 6 articles (01/2015 - 04/2011)|
|1.||Migraine Disorders (Migraine)
11/01/2009 - "Intrapatient comparisons showed that most patients with migraine reported significantly improved effectiveness and tolerability ratings with frovatriptan versus previous acute therapies."
09/01/2006 - "Earlier clinical trials demonstrated that frovatriptan 2.5 mg is significantly more effective than placebo in the acute management of migraine and its associated symptoms. "
03/01/2013 - "More well-designed, randomized, prospective studies, specifically enrolling women with MM, will be needed in the near future to confirm the efficacy of frovatriptan in this migraine subtype."
08/01/2011 - "The initiation of attack treatment with frovatriptan at low severity of migraine symptoms is more effective than starting therapy at higher symptom levels. "
09/01/2006 - "More recently, frovatriptan was shown to be effective in the management of menstrual migraine. "
04/01/2002 - "In all three studies, headache response 2 hours after frovatriptan dosing was significantly greater than that seen with placebo (P < or = .001) with approximately a two-fold measure of effect over placebo for headache response at 2 and 4 hours postdosing. "
01/01/2010 - "A similar number judged the efficacy of frovatriptan against headache as "better" than previous treatment. "
01/01/2002 - "A previous study has shown that frovatriptan doses of 2.5, 5, 10, 20, and 40 mg are equally effective in relieving headache with no evidence of a dose-response relationship. "
05/01/2013 - "In this open preliminary trial, we tested the efficacy of associating frovatriptan and dexketoprofen for the treatment of an acute attack of MRM, diagnosed according to the criteria of the International Headache Society, in 24 patients between 19 and 45 years of age (mean 31.33 ± 7.33). "
12/01/2005 - "In those whose headache was relieved at 4 h, the risk of headache recurrence within 24 h was reduced by 26% with frovatriptan (RR 0.74, 95% CI 0.59-0.93, P = 0.009). "
01/01/2010 - "Frovatriptan in the practice of office-based neurologists/pain therapists: Results of postmarketing surveillance study ALADIN."
05/01/2014 - "Pain relapse occurred at 48 h in significantly (p < 0.05) fewer episodes treated with frovatriptan in both NO (26 vs. 36 %) and O (27 vs. 49 %). "
05/01/2014 - "Pain relief was also similar between treatments for both genders (men: 56 % frovatriptan vs. 57 % comparators; women: 55 vs. 57 %; p = NS for both). "
05/01/2013 - "Pain relief was achieved in significantly (p < 0.05) fewer episodes in HT subjects for both frovatriptan (41 vs. 52 % NT) and the comparators (48 vs. 58 %). "
09/01/2012 - "In a further trial, frovatriptan administered early in a migraine attack was more efficacious than placebo followed by later administration of frovatriptan as pain progressed. "
04/01/1996 - "The authors have used the frameless stereotactic Allegro Viewing Wand System to provide real-time correlation of the operating field and computerized images in over 200 neurosurgical operations carried out for intractable epilepsy. "
10/01/1994 - "The authors have used the frameless stereotactic Allegro Viewing Wand system to provide real-time correlation of the operating field and computerized images in 42 neurosurgical operations, including 31 epilepsy procedures. "
05/01/2014 - "Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura."
05/01/2015 - "In this double-blind, randomized parallel group study 314 subjects with acute migraine with or without aura were randomly assigned to Frova, FroDex 25, or FroDex 37.5. "
05/01/2015 - "Early (≤ 1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study."
|5.||Migraine with Aura (Familial Hemiplegic Migraine)
05/01/2012 - "Our study suggests that frovatriptan is superior to zolmitriptan in the immediate treatment of patients with migraine with aura, and it is capable of maintaining its acute analgesic effect over 48 h."
05/01/2012 - "The aim of this study was to compare the efficacy of frovatriptan 2.5 mg and zolmitriptan 2.5 mg in the treatment of migraine with aura. "
01/01/2015 - "Efficacy of frovatriptan as compared to other triptans in migraine with aura."
05/01/2012 - "Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian study."
|7.||Serotonin (5 Hydroxytryptamine)